Amlodipine-induced gingival overgrowth in a child after liver transplant.

about

Amlodipine-induced gingival overgrowth in a child after liver transplant.

Item

http://www.wikidata.org/entity/Q41629774

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Amlodipine-induced gingival overgrowth in a child after liver transplant.

@en

type

Item

label

Amlodipine-induced gingival overgrowth in a child after liver transplant.

@en

prefLabel

Amlodipine-induced gingival overgrowth in a child after liver transplant.

@en

P1476

Amlodipine-induced gingival overgrowth in a child after liver transplant.

@en

P2093

Ana Paula Molina Vivas

http://www.w3.org/2001/XMLSchema#string

André Guollo

http://www.w3.org/2001/XMLSchema#string

Fábio Abreu Alves

http://www.w3.org/2001/XMLSchema#string

Gilda Porta

http://www.w3.org/2001/XMLSchema#string

Rodrigo Nascimento Lopes

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis

Posttransplantation hypertension related to calcineurin inhibitors.

Amlodipine-induced massive gingival hypertrophy.

Management of amlodipine-induced gingival enlargement: Series of three cases.

Incidence of amlodipine-induced gingival overgrowth in the rural population of Loni.

Tacrolimus is not associated with gingival overgrowth in renal transplant patients.

Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens.

Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada.

Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial.

Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers.

P304

47-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4322/ACR.2016.041

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27818959

http://www.w3.org/2001/XMLSchema#string

P932

5087984

http://www.w3.org/2001/XMLSchema#string